IMO capital intensity on an per EBITDA basis will be very attractive indeed.
Should be very low technical risk too due to very simple flow sheet.
Ann: Joint Venture for Advanced Nanomaterial Research Formalised, page-166
Add ADN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $31.10M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.1¢ | 0.9¢ | $503.0K | 52.84M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 4749269 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 17804638 | 18 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| ADN (ASX) Chart |